Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
Episteme Prognostics has raised $5.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Episteme Prognostics is headquartered in New York, United States.
Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
Episteme Prognostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Episteme Prognostics — Funding & Investors." VCBacked, September 4, 2026, https://www.vcbacked.co/company/episteme-prognostics. Accessed November 14, 2026.
VCBacked. (2026). Episteme Prognostics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/episteme-prognostics
{{cite web |title=Episteme Prognostics — Funding & Investors |url=https://www.vcbacked.co/company/episteme-prognostics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Episteme Prognostics? Request a listing update